Filing Analysis
Officer Departure
Filed Mar 30, 2026
LOW
Champions Oncology announced the resignation of Dr. Philip Breitfeld from its Board of Directors and the concurrent appointment of Dr. Brian Alexander to fill the vacancy. Dr. Alexander brings extensive experience in oncology and data science from leadership roles at Valo Health, Roche/Genentech, and Foundation Medicine.
Key Facts
- Dr. Philip Breitfeld resigned from the Board of Directors on March 24, 2026.
- Dr. Brian Alexander was appointed as a director on March 24, 2026.
- Dr. Alexander is the current CEO of Valo Health Inc. and a CEO-Partner at Flagship Pioneering.
- Dr. Alexander's previous roles include CEO of Foundation Medicine and Senior Vice President for Research & Development at Roche/Genentech.
- The company stated the resignation was not due to any disagreement regarding operations, policies, or practices.
Regulation FD Disclosure
Filed Mar 12, 2026
LOW
Champions Oncology, Inc. announced its unaudited financial results for the third fiscal quarter ended January 31, 2026. The results were disclosed via a press release on March 12, 2026, and filed under Item 2.02.
Key Facts
- The filing reports financial results for the third fiscal quarter ended January 31, 2026.
- The announcement was made on March 12, 2026.
- The company utilized Item 2.02 (Results of Operations and Financial Condition) for the disclosure.
- A press release was attached as Exhibit 99.1.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.